Research University newsletter – a source of information for the MUG researchers

After several months of distributing the newsletter to those involved in the work of Priority Research Areas, we have decided to expand the group of its recipients. Starting with this issue, every two weeks, we will inform all research and research and teaching staff of the University about interesting events, initiatives and open grant competitions.
We are open to your opinions and suggestions. We are also waiting for selected news from the units, which may be of interest to other researchers.
We invite you to read!

The team of the Administration Department for the "Excellence Initiative - Research University" Program

Incubator  funding for implementation projects

The program provides an opportunity to receive up to 150 thousand PLN of support for a single project including, among others, costs of laboratory work, purchase of materials and raw materials, or research services necessary for the proper implementation of the measure. The allocation of funds for the current call for proposals is 450 thousand PLN.

Research funding may be applied for by University employees and participants of full-time doctoral studies and students of the First Doctoral School of the Medical University of Gdańsk who research with implementation potential. Support may be granted to projects whose degree of technological maturity is between TRL IV and TRL VI (prototype phase) of the Technology Readiness Level scale. Preference will be given to initiatives whose subject matter falls within the scope of Priority Research Areas.

The deadline for submission of applications is December 22, 2021. Detailed information about the call for proposals and the necessary documentation can be found on the website of the Technology Transfer Office. Marcin Stolarek from Technology Transfer Office of the MUG (Phone: 58 349 10 09, E-mail: also provides more information.

You can read about other initiatives within the Research University program here.

Supporting structures - Bioanalytical Laboratory

The Bioanalytical Laboratory is one of the support structures established within the Excellence Initiative - Research University Program. The team of analysts and bioanalysts provides assistance at all stages of the drug development process - from preclinical studies (ADME), through bioequivalence (BE) and pharmacokinetics (PK), to clinical trials (including statistical calculations) and drug registration support. The Laboratory services include qualitative and quantitative determination of compounds and their metabolites in biological samples of human or animal origin, such as plasma, serum, whole blood, urine, saliva, feces, tissues, etc.
The Bioanalytical Laboratory has a certificate of Good Laboratory Practice (GLP), which is a confirmation of a high level of quality and reliability of research. The results obtained in the Laboratory are recognized by such authorities and institutions as the European Medicines Agency (EMA) and the Food and Drug Administration (FDA).
The detailed offer of the Laboratory can be found here
We also encourage you to use the offer of other support structures 
Millions for cooperation between science and business

15 million PLN - this is the total value of grants that entrepreneurs will be able to use to purchase research and development services under the project R&D Microgrants for Enterprises implemented by the Centre for Medical Innovations (Centrum Innowacji Medycznych) in cooperation with Excento sp. z o.o., Univentum Labs sp. z o.o. and the Pomeranian Regional Chamber of Commerce.
The aim of the project co-financed by the EU is to build cooperation between science and business by improving access to advanced research services that can be implemented, among others, by research teams of the Medical University of Gdańsk.
Information about the project and the possibilities of providing services under it can be found at or obtained from the Centre for Medical Innovations (tel. 58 349 10 09, e-mail:
Funding opportunities within the EIT Health partnership

Joining the group of Partners of the European Institute of Innovation and Technology in Health (EIT Health) opens the possibility of applying for grants in scientific and business cooperation in international consortia for programs:
- innovative, which include topics such as: oncology, cardiovascular system, immune system, endocrinology, diagnostics, rehabilitation, mental health (max. funding for the consortium is 2.5 million euros for three years; the proposed activities are to result in innovation, and after market launch, generate revenue);
- educational, aimed at designing, developing and delivering innovative and high quality educational, training and awareness-raising activities for health professionals, entrepreneurs, citizens and patients across Europe (maximum consortium funding EUR 1 million per year);
- acceleration, dedicated to start-ups.
For more information, please visit or contact the Technology Transfer Office (E-mail
Open grant competitions

PRELUDIUM BIS 3 competition to support doctoral schools in educating doctoral students and financing research projects carried out by them as part of their doctoral dissertations. Both research and PhD scholarships can be financed. The deadline for applications is December 15 of this year.

NAWA Urgency Grants for international cooperation of research teams or international mobility of scientists, which are undertaken in response to sudden, important, unforeseen social, civilizational and natural phenomena of global or regionally significant consequences. Recruitment on a rolling basis.

START Program a competition for scientific fellowships awarded to outstanding young scholars (under 30 years of age) with documented achievements in their field of research. The application deadline is November 22 this year.
Upcoming events

Nov. 26, 2021, 9:30 a.m. (online)
Horizon Europe webinar and broker meeting: Tackling Diseases and AMR
The webinar will be an opportunity to learn about the competition themes, present your institution, network and join potential consortia in the competition themes of the Health cluster:
- HORIZON-HLTH-2022-DISEASE-06-02-two-stage: Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs;
- HORIZON-HLTH-2022-DISEASE-06-03-two-stage: Vaccines 2.0 - developing the next generation of vaccines;
- HORIZON-HLTH-2022-DISEASE-06-04-two-stage: Development of new effective therapies for rare diseases;
- HORIZON-HLTH-2022-DISEASE-07-02: Pandemic preparedness;
- HORIZON-HLTH-2022-DISEASE-07-03: Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD);
- HORIZON-HLTH-2022-TOOL-11-02: New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment.
Registration for the meeting can be made at the website, where a detailed agenda is also available.
Past events 

20.10.2021 In vivo research at the MUG - let's get to know each other!

67 people took part in a webinar entitled “In vivo research at GUMed – let’s get to know each other!” organised under Priority Research Area 3 by Team V (In vivo studies on the mechanism of disease and therapy) under the “Excellence Initiative – Research University” program. The meeting was held on October 20, 2021, via Clickmeeting. The invitation to participate was addressed to scientists of the Medical University of Gdańsk, the University of Gdańsk, and the Gdańsk University of Technology.

The summary from the event is available at the website.

Recommended publications

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer [Dokument elektroniczny]. Golden Emily, Rashwan Rabab, Woodward Eleanor A., Sgro Agustin, Wang Edina, Sorolla Anabel, Waryah Charlene, Tie Wan Jun, Cuyas Elisabet, RATAJSKA MAGDALENAKARDAŚ IWONA, Kozlowski Piotr, Johnstone Elizabeth K. M., See Heng B., Duffy Ciara, Parry Jeremy, Lagerborg Kim A., Czapiewski Piotr, Menendez Javier A., GORCZYŃSKI ADAMWASĄG BARTOSZ, Pfleger Kevin D. G., Curtis Christina, Lee Bum-Kyu, Kim Jonghwan, Cursons Joseph, Pavlos Nathan J., BIERNAT WOJCIECH, Jain Mohit, Woo Andrew J., Redfern Andrew, Blancafort Pilar, Nature Communications, 2021, vol. 12 (1), s. 1-22.

Adipose-derived stromal cells for nonhealing wounds : emerging opportunities and challenges. DEPTUŁA MILENA, Brzezicka Agnieszka, SKONIECKA ANETAZIELIŃSKI JACEKPIKUŁA MICHAŁ, Medicinal Research Reviews, 2021, vol. 41  (4), s. 2130-2171.

Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells [Dokument elektroniczny]. Bilska Bernadetta, Schedel Fiona, PIOTROWSKA ANNA, Stefan Joanna, ŻMIJEWSKI MICHAŁ, Pyza Elżbieta, Reiter Russel J., Steinbrink Kerstin, Slominski Andrzej T., Tulic Meri K., Kleszczyński Konrad, Journal of Pineal Research, 2021, vol. 70 (3), s. 1-19. 
Copyright © Medical University of Gdańsk, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.